Technical Analysis for DMTK - DermTech, Inc.

Grade Last Price % Change Price Change
D 37.49 -13.74% -5.97
DMTK closed down 13.74 percent on Monday, April 19, 2021, on 1.67 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical DMTK trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Buy Signal Bullish -13.74%
NR7 Range Contraction -13.74%
Inside Day Range Contraction -13.74%
Wide Bands Range Expansion -13.74%
Older End-of-Day Signals for DMTK ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
1.5x Volume Pace about 13 hours ago
Fell Below Lower Bollinger Band about 14 hours ago
Lower Bollinger Band Support about 15 hours ago
Down 1 ATR about 15 hours ago
Trending on StockTwits about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


DermTech, Inc. Description

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.


Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Cancer Melanoma Gene Expression Dermatology Diagnostic Tests Risk Assessment Pathology Biopsy Assessment Products Skin Cancer Melanoma Skin Cancer Pigmented Lesion Cutaneous Conditions

Is DMTK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 84.49
52 Week Low 9.64
Average Volume 1,600,082
200-Day Moving Average 26.92
50-Day Moving Average 56.61
20-Day Moving Average 48.54
10-Day Moving Average 45.50
Average True Range 5.10
ADX 21.71
+DI 13.88
-DI 33.74
Chandelier Exit (Long, 3 ATRs ) 51.59
Chandelier Exit (Short, 3 ATRs ) 52.03
Upper Bollinger Band 59.99
Lower Bollinger Band 37.09
Percent B (%b) 0.02
BandWidth 47.17
MACD Line -3.67
MACD Signal Line -2.73
MACD Histogram -0.9341
Fundamentals Value
Market Cap 734.63 Million
Num Shares 19.6 Million
EPS -3.08
Price-to-Earnings (P/E) Ratio -12.17
Price-to-Sales 35.67
Price-to-Book 4.76
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 46.66
Resistance 3 (R3) 47.42 45.14 45.13
Resistance 2 (R2) 45.14 42.80 44.75 44.62
Resistance 1 (R1) 41.31 41.36 40.17 40.55 44.11
Pivot Point 39.03 39.03 38.46 38.64 39.03
Support 1 (S1) 35.20 36.69 34.06 34.44 30.87
Support 2 (S2) 32.92 35.25 32.53 30.36
Support 3 (S3) 29.09 32.92 29.85
Support 4 (S4) 28.33